Meridian Bioscience (VIVO) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Meridian Bioscience Reports First Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance
January 27, 2016 7:30 AM ESTGENERAL HIGHLIGHTS
CINCINNATI, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
reported first quarter net revenues of $47.2 million, a decrease of 2% from the same period of the prior fiscal year; reported first quarter operating income of $13.6 million, an increase of 7% from the same period of the prior fiscal year; reported first quarter net earnings of $8.9 million, or $0.21 per diluted share, increases of 13%... More


